Fate Therapeutics
FATE
FATE
137 hedge funds and large institutions have $88.8M invested in Fate Therapeutics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+7
Holders Change %
+5.38%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
45
Reduced
40
Closed
21
Calls
$264K
Puts
$40K
Net Calls
+$224K
Net Calls Change
+$166K
Top Buyers
1 |
Millennium Management
New York
|
$985K |
2 |
Jane Street
New York
|
$522K |
3 |
AQR Capital Management
Greenwich,
Connecticut
|
$948K |
4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$288K |
5 |
Citadel Advisors
Miami,
Florida
|
$5.09M |
Top Sellers
1 |
SSA
Schonfeld Strategic Advisors
New York
|
$1.04M |
2 |
![]()
JPMorgan Chase & Co
New York
|
$65.6K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$9.82M |
4 |
O
OrbiMed
New York
|
$0 |
5 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.36M |